Target intelligence / Profile preview

DNA polymerase delta subunit 4 (POLD4)

Target
POLD4
Molecular classification
Enzyme (DNA-directed polymerase complex component), Polymerase subunit, DNA replication protein, Accessory subunit
01

Overview

DNA polymerase delta subunit 4 (POLD4, also known as p12) is the smallest accessory subunit of the tetrameric DNA polymerase delta complex, which is a major eukaryotic DNA polymerase required for high-fidelity DNA replication and repair. POLD4 enhances the rate of DNA synthesis and modulates the proofreading activity of the complex by regulating the main catalytic subunit (POLD1). Under replication stress or DNA damage, POLD4 can be degraded, altering the polymerase composition and activity to favor repair and cell survival. POLD4 is implicated in several DNA repair pathways (e.g., base excision repair, Okazaki fragment processing, translesion synthesis), and plays a structural and functional role in maintaining genome stability in dividing cells.

Other names
DNA polymerase delta 4, accessory subunitP12POLDSDNA polymerase delta smallest subunit P12DNA polymerase delta subunit 4DNA polymerase delta subunit P12Polymerase (DNA-directed), delta 4, accessory subunitPolymerase (DNA) delta 4, accessory subunit
02

Mechanism of action

Indirectly, drugs targeting DNA replication may impair DNA polymerase delta activity, often by incorporation of nucleotide analogs or causing DNA damage. Any hypothetical direct POLD4-targeted drug would likely affect DNA replication fidelity, repair, or processivity.

03

Biological functions

DNA replicationDNA repair (e.g., base excision repair, Okazaki fragment processing)Replicative fidelity and proofreading (regulates both polymerase and exonuclease activity)DNA synthesis at replication forks; role in replication fork repair and stabilization through interaction with Bloom syndrome proteinParticipates in translesion synthesis (TLS), especially under DNA damage stress
04

Disease associations

Cancer (due to its essential role in genome stability and replication fidelity)Xeroderma pigmentosum group G (from associated gene variant)Genomic instability disorders (via defective DNA repair or replication)Other diseases involving impaired DNA repair, genome duplication, and mutagenesis
05

Safety considerations

Essential for cell viability: inhibition or dysfunction leads to replication failure, genome instability, and cell deathPotential mutagenesis: if fidelity is compromised, this could increase cancer risk or disease severityToxicity/challenge in targeting: as a housekeeping replication factor, systemic inhibition presents narrow therapeutic windows and off-target toxicity

Beyond the preview

Go deeper on DNA polymerase delta subunit 4 (POLD4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase delta subunit 4 (POLD4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call